Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer.

EMT GLYAT PI3K/AKT breast cancer clinicopathological features prognosis

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 12 10 2021
accepted: 04 03 2022
entrez: 25 4 2022
pubmed: 26 4 2022
medline: 26 4 2022
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fonc.2021.641399.].

Identifiants

DOI: 10.3389/fonc.2022.793448 PMID: 35463385 PMC: PMC9020255
pubmed: 35463385
doi: 10.3389/fonc.2022.793448
pmc: PMC9020255
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

793448

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2022 Tian, Wu, Jiang, Zhang, Wu, Miao, Liu and Gao.

Auteurs

Xin Tian (X)

Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.

Lina Wu (L)

Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.

Min Jiang (M)

Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.

Zhenyong Zhang (Z)

Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.

Rong Wu (R)

Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.

Jianing Miao (J)

Key Laboratory of Shengjing Hospital, China Medical University, Shenyang, China.

Caigang Liu (C)

Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.

Song Gao (S)

Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.

Classifications MeSH